Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID-19
- PMID: 35150456
- PMCID: PMC9111264
- DOI: 10.1111/all.15253
Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID-19
Keywords: COVID; basic immunology; lung diseases other than asthma and COPD.
Conflict of interest statement
LOM is a consultant to PrecisionBiotics and has received research funding from GSK and Chiesi. LOM has participated in speaker's bureau for Nestle, Nutricia, Reckitt, and Abbott. WCA has participated in advisory boards for Pfizer, MSD, and Sanofi, with reimbursements paid to his institution. None of the other authors report any conflict of interest.
Figures


References
-
- World Health Organization . A clinical case definition of post COVID‐19 condition by a Delphi consensus. Published Online October 6, 2021. https://www.who.int/publications/i/item/WHO‐2019‐nCoV‐Post_COVID‐19_cond...
-
- Albrich WC, Ghosh TS, Ahearn‐Ford S, et al. A high‐risk gut microbiota configuration associates with hyperinflammatory immune and metabolic responses to acute SARS‐CoV‐2 infection. Preprint: https://biorxiv.org/cgi/content/short/2021.10.26.465865v1 - PMC - PubMed
-
- Reis G, dos Santos Moreira‐Silva EA, Medeiros‐Silva DC, et al. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID‐19: The TOGETHER randomised, platform clinical trial. Lancet Glob Health. 2022;10(1):e42‐e51. doi:10.1016/S2214-109X(21)00448-4. (published online Oct 27.). - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical